bepridil and penicillamine

bepridil has been researched along with penicillamine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barneveld, A; Helms, JB; Huitema, LF; Vaandrager, AB; van de Lest, CH; van Weeren, PR	1

Other Studies

2 other study(ies) available for bepridil and penicillamine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Iron ions derived from the nitric oxide donor sodium nitroprusside inhibit mineralization. European journal of pharmacology, 2006, Aug-07, Volume: 542, Issue:1-3 Topics: Animals; Bepridil; Calcium; Catalase; Cell Line; Cyclic N-Oxides; Dose-Response Relationship, Drug; Ferric Compounds; Ferricyanides; Ferrous Compounds; Free Radical Scavengers; Imidazoles; Iron; Mannitol; Minerals; Molecular Structure; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxidation-Reduction; Penicillamine; Quaternary Ammonium Compounds; Reactive Oxygen Species; S-Nitrosoglutathione; Superoxide Dismutase	2006

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Iron ions derived from the nitric oxide donor sodium nitroprusside inhibit mineralization.

European journal of pharmacology, 2006, Aug-07, Volume: 542, Issue:1-3

Topics: Animals; Bepridil; Calcium; Catalase; Cell Line; Cyclic N-Oxides; Dose-Response Relationship, Drug; Ferric Compounds; Ferricyanides; Ferrous Compounds; Free Radical Scavengers; Imidazoles; Iron; Mannitol; Minerals; Molecular Structure; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxidation-Reduction; Penicillamine; Quaternary Ammonium Compounds; Reactive Oxygen Species; S-Nitrosoglutathione; Superoxide Dismutase

2006